CAR T Archives - Page 2 of 15 -

Cellular Immunotherapies for Solid Tumors Summit

https://pharmaphorum.com/events/cellular-immunotherapies-for-solid-tumors-summit/

CAR-T Beyond Oncology Digital Summit

https://pharmaphorum.com/events/car-t-beyond-oncology-digital-summit/

FDA’s review date for BMS’ ide-cel sneaks under the CVR wire

https://pharmaphorum.com/news/fdas-review-date-for-bms-ide-cel-sneaks-under-the-cvr-wire/

Preparing for an influx of cell and gene therapy approvals

https://pharmaphorum.com/views-analysis-sales-marketing/preparing-influx-cell-gene-therapy-approvals/

BMS ‘bet’ with Celgene shareholders in balance after CAR-T refile

https://pharmaphorum.com/news/bms-2/

Gilead’s Kite gains some height after second CAR-T approval in US

https://pharmaphorum.com/news/gileads-kite-gains-some-height-after-second-car-t-approval-in-us/

Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D

https://pharmaphorum.com/news/poseida-therapeutics/

ASCO 2020 round-up: Virtual conference still delivers the drama

https://pharmaphorum.com/views-analysis-oncology/asco-2020-round-up-virtual-conference-still-delivers-the-drama/

Competition heats up in BCMA CAR-T as J&J, BMS update myeloma trials

https://pharmaphorum.com/news/bcma-jnj-bms-myeloma-trials/

Search